Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Point32Health | Botulinum ToxinsPayerPolicy · POINT32HEALTH-MDMNG-12491 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Bevacizumab ProductsPayerPolicy · POINT32HEALTH-MDMNG-24066 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Benlysta (belimumab) IntravenousPayerPolicy · POINT32HEALTH-MDMNG-12471 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Benlysta (belimumab) IntravenousPayerPolicy · POINT32HEALTH-MDMNG-12461 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Benlysta (belimumab)PayerPolicy · POINT32HEALTH-MDMNG-12451 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Avastin (bevacizumab) for ophthalmic conditions ONLYPayerPolicy · POINT32HEALTH-MDMNG-12441 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Aucatzyl (obecabtagene autoleucel)PayerPolicy · POINT32HEALTH-MDMNG-12431 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Aucatzyl (obecabtagene autoleucel)PayerPolicy · POINT32HEALTH-MDMNG-12421 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Asparaginase ProductsPayerPolicy · POINT32HEALTH-MDMNG-12411 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Antipsychotic MedicationsPayerPolicy · POINT32HEALTH-MDMNG-12391 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Anktiva (nogapendekin alfa inbakiceptpmln)PayerPolicy · POINT32HEALTH-MDMNG-12381 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Anktiva (nogapendekin alfa inbakicept-pmln)PayerPolicy · POINT32HEALTH-MDMNG-12371 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amyloidosis TherapiesPayerPolicy · POINT32HEALTH-MDMNG-12361 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amyloidosis TherapiesPayerPolicy · POINT32HEALTH-MDMNG-12351 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amtagvi (lifileucel)PayerPolicy · POINT32HEALTH-MDMNG-12341 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amtagvi (lifileucel)PayerPolicy · POINT32HEALTH-MDMNG-12331 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amondys45 (casimersen)PayerPolicy · POINT32HEALTH-MDMNG-12321 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Amondys 45 (casimersen)PayerPolicy · POINT32HEALTH-MDMNG-12311 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Altuviiio [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl]PayerPolicy · POINT32HEALTH-MDMNG-12301 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Altuviiio (antihemophilic factor [recombinant], Fc-VWF-XTEN fusion protein-ehtl)PayerPolicy · POINT32HEALTH-MDMNG-12291 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Alpha1-Proteinase InhibitorsPayerPolicy · POINT32HEALTH-MDMNG-12281 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Alhemo (concizumab-mtci)PayerPolicy · POINT32HEALTH-MDMNG-12261 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Alhemo (concizumab-mtci)PayerPolicy · POINT32HEALTH-MDMNG-12271 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Ajovy (fremanezumab-vfrm)PayerPolicy · POINT32HEALTH-MDMNG-12251 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adzynma (ADAMTS13, recombinantkrhn)PayerPolicy · POINT32HEALTH-MDMNG-12241 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adzynma (ADAMTS13, recombinantkrhn)PayerPolicy · POINT32HEALTH-MDMNG-12231 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adzynma (ADAMTS13, recombinantkrhn)PayerPolicy · POINT32HEALTH-MDMNG-12221 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Advanced Parkinson’s Disease MedicationsPayerPolicy · POINT32HEALTH-MDMNG-14241 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adstiladrin (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-12211 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adstiladrin (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-28461 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adstiladrin (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-12201 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Adakveo (crizanlizumab-tmca)PayerPolicy · POINT32HEALTH-MDMNG-12191 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Abraxane (paclitaxel protein bound)PayerPolicy · POINT32HEALTH-MDMNG-24056 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Abilify Asimtufii (aripiprazole extended-release injection)PayerPolicy · POINT32HEALTH-MDMNG-12171 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Abecma (idecabtagene vicleucel)PayerPolicy · POINT32HEALTH-MDMNG-12161 | New policy |
|---|
| Aug 2, 2026 | Point32Health | Abecma (idecabtagene vicleucel)PayerPolicy · POINT32HEALTH-MDMNG-12151 | New policy |
|---|
| Aug 2, 2026 | Point32Health | ADSTILADRIN (nadofaragene firadenovec-vncg)PayerPolicy · POINT32HEALTH-MDMNG-28471 | New policy |
|---|
| Aug 2, 2026 | Oscar Health | sodium oxybate (Xyrem) (PG009, Ver. 9)PayerPolicy · OSCAR-PG009-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | sildenafil (PAH, Viagra) (PG051, Ver. 8)PayerPolicy · OSCAR-PG051-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | paroxetine 7.5 mg capsule (PG272, Ver. 2)PayerPolicy · OSCAR-PG272-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | lamotrigine extended release (Lamictal XR) (PG055, Ver7)PayerPolicy · OSCAR-LAMOTRIGINE-EXTENDED-RELEASE-LAMICTAL-XR-PG05-338BFF31F5 | New policy |
|---|
| Aug 2, 2026 | Oscar Health | fingolimod (Gilenya, Tascenso ODT) (PG224, Ver. 3)PayerPolicy · OSCAR-PG224-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | asenapine (Saphris) (PG058, Ver. 8)PayerPolicy · OSCAR-PG058-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | armodafinil (Nuvigil) (PG036, Ver. 9)PayerPolicy · OSCAR-PG036-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | albendazole (Albenza) (PG101, Ver. 6)PayerPolicy · OSCAR-PG101-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | Zynteglo (betibeglogene autotemcel) (CG073)PayerPolicy · OSCAR-ZYNTEGLO-BETIBEGLOGENE-AUTOTEMCEL-CG073-C54796FA04 | New policy |
|---|
| Aug 2, 2026 | Oscar Health | Zurzuvae (zuranolone) (PG182, Ver. 3)PayerPolicy · OSCAR-PG182-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | Zortress (everolimus) (PG033, Ver. 7)PayerPolicy · OSCAR-PG033-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | Onasemnogene abeparvovec (Zolgensma [-xioi]; Itvisma, [-brve]) (CG061, Ver. 6)PayerPolicy · OSCAR-CG061-PHARMACY | New policy |
|---|
| Aug 2, 2026 | Oscar Health | Zokinvy (lonafarnib) (PG092, Ver. 7)PayerPolicy · OSCAR-PG092-PHARMACY | New policy |
|---|